Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Profit After Tax (2020 - 2025)

Historic Profit After Tax for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to -$110.2 million.

  • Agilon Health's Profit After Tax rose 629.85% to -$110.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$308.3 million, marking a year-over-year increase of 1990.15%. This contributed to the annual value of -$260.2 million for FY2024, which is 100.91% up from last year.
  • As of Q3 2025, Agilon Health's Profit After Tax stood at -$110.2 million, which was up 629.85% from -$104.4 million recorded in Q2 2025.
  • Over the past 5 years, Agilon Health's Profit After Tax peaked at $16.0 million during Q1 2023, and registered a low of -$298.9 million during Q2 2021.
  • For the 5-year period, Agilon Health's Profit After Tax averaged around -$65.3 million, with its median value being -$31.5 million (2023).
  • Its Profit After Tax has fluctuated over the past 5 years, first plummeted by 367880.17% in 2021, then skyrocketed by 120260.16% in 2023.
  • Quarter analysis of 5 years shows Agilon Health's Profit After Tax stood at -$56.7 million in 2021, then increased by 1.21% to -$56.0 million in 2022, then crashed by 311.22% to -$230.5 million in 2023, then surged by 54.1% to -$105.8 million in 2024, then dropped by 4.18% to -$110.2 million in 2025.
  • Its last three reported values are -$110.2 million in Q3 2025, -$104.4 million for Q2 2025, and $12.1 million during Q1 2025.